LAMICTAL XR

Lamictal Xr Adverse Events Reported to the FDA Over Time

How are Lamictal Xr adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lamictal Xr, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lamictal Xr is flagged as the suspect drug causing the adverse event.

Most Common Lamictal Xr Adverse Events Reported to the FDA

What are the most common Lamictal Xr adverse events reported to the FDA?

Convulsion	86 (10.51%)
Drug Ineffective	31 (3.79%)
Rash	30 (3.67%)
Vomiting	22 (2.69%)
Nausea	21 (2.57%)
Dizziness	20 (2.44%)
Grand Mal Convulsion	18 (2.2%)
Headache	16 (1.96%)
Overdose	14 (1.71%)
Product Quality Issue	13 (1.59%)
Somnolence	13 (1.59%)
	Show More
Drug Level Decreased	12 (1.47%)
Fall	11 (1.34%)
Stevens-johnson Syndrome	11 (1.34%)
Tremor	11 (1.34%)
Adverse Drug Reaction	9 (1.1%)
Pruritus	9 (1.1%)
Vision Blurred	9 (1.1%)
Diplopia	8 (.98%)
Malaise	8 (.98%)
Ill-defined Disorder	7 (.86%)
Insomnia	7 (.86%)
Loss Of Consciousness	7 (.86%)
Visual Impairment	7 (.86%)
Anger	6 (.73%)
Balance Disorder	6 (.73%)
Drug Administration Error	6 (.73%)
Memory Impairment	6 (.73%)
Treatment Noncompliance	6 (.73%)
Adverse Event	5 (.61%)
Blindness	5 (.61%)
Bronchitis	5 (.61%)
Erythema Multiforme	5 (.61%)
Fatigue	5 (.61%)
Feeling Abnormal	5 (.61%)
Migraine	5 (.61%)
Petit Mal Epilepsy	5 (.61%)
Staring	5 (.61%)
Urticaria	5 (.61%)
Contusion	4 (.49%)
Disorientation	4 (.49%)
Drug Intolerance	4 (.49%)
Impaired Driving Ability	4 (.49%)
Inappropriate Schedule Of Drug Admi...	4 (.49%)
Pain	4 (.49%)
Pyrexia	4 (.49%)
Skin Exfoliation	4 (.49%)
Swollen Tongue	4 (.49%)
Thermal Burn	4 (.49%)
Aggression	3 (.37%)
Amnesia	3 (.37%)
Cardiac Disorder	3 (.37%)
Condition Aggravated	3 (.37%)
Coordination Abnormal	3 (.37%)
Diarrhoea	3 (.37%)
Drug Level Increased	3 (.37%)
Dyskinesia	3 (.37%)
Erythema	3 (.37%)
Expired Drug Administered	3 (.37%)
Eye Movement Disorder	3 (.37%)
Hallucination	3 (.37%)
Incorrect Storage Of Drug	3 (.37%)
Irritability	3 (.37%)
Lethargy	3 (.37%)
Medication Error	3 (.37%)
Medication Residue	3 (.37%)
Myalgia	3 (.37%)
Panic Attack	3 (.37%)
Stress	3 (.37%)
Vertigo	3 (.37%)
Viral Infection	3 (.37%)
Visual Acuity Reduced	3 (.37%)
Weight Increased	3 (.37%)
Abasia	2 (.24%)
Abdominal Discomfort	2 (.24%)
Abnormal Dreams	2 (.24%)
Bedridden	2 (.24%)
Blister	2 (.24%)
Blood Sodium Decreased	2 (.24%)
Brain Mass	2 (.24%)
Chills	2 (.24%)
Constipation	2 (.24%)
Dehydration	2 (.24%)
Disability	2 (.24%)
Drug Eruption	2 (.24%)
Drug Exposure During Pregnancy	2 (.24%)
Drug Screen Positive	2 (.24%)
Drug Toxicity	2 (.24%)
Dysgeusia	2 (.24%)
Dyspnoea	2 (.24%)
Ear Pain	2 (.24%)
Eye Swelling	2 (.24%)
Feeling Drunk	2 (.24%)
Feeling Hot	2 (.24%)
Hot Flush	2 (.24%)
Hyperhidrosis	2 (.24%)
Hypersensitivity	2 (.24%)
Influenza	2 (.24%)
Influenza Like Illness	2 (.24%)
Local Swelling	2 (.24%)
Lymphadenopathy	2 (.24%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Lamictal Xr, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lamictal Xr is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lamictal Xr

What are the most common Lamictal Xr adverse events reported to the FDA?

Seizures	111 (13.57%)
Epidermal And Dermal Conditions	80 (9.78%)
Neurological	70 (8.56%)
Gastrointestinal Signs	56 (6.85%)
Therapeutic And Nontherapeutic Effe...	52 (6.36%)
Medication Errors	36 (4.4%)
Vision	32 (3.91%)
Headaches	21 (2.57%)
Injuries	18 (2.2%)
Product Quality Issues	18 (2.2%)
Toxicology And Therapeutic Drug Mon...	17 (2.08%)
	Show More
Lifestyle Issues	16 (1.96%)
Movement Disorders	16 (1.96%)
Infections - Pathogen Unspecified	12 (1.47%)
Sleep Disorders	11 (1.34%)
Mental Impairment	10 (1.22%)
Anxiety Disorders	9 (1.1%)
Mood Disorders	7 (.86%)
Psychiatric And Behavioural Symptom...	7 (.86%)
Respiratory	7 (.86%)
Viral Infectious	7 (.86%)
Personality Disorders	6 (.73%)
Angiedema And Urticaria	5 (.61%)
Cardiac Disorder Signs	5 (.61%)
Deliria	5 (.61%)
Gastrointestinal Motility And Defec...	5 (.61%)
Inner Ear And Viiith Cranial Nerve	5 (.61%)
Menstrual Cycle And Uterine Bleedin...	5 (.61%)
Muscle	5 (.61%)
Body Temperature Conditions	4 (.49%)
Bone And Joint Injuries	4 (.49%)
Chemical Injury And Poisoning	4 (.49%)
Disturbances In Thinking	4 (.49%)
Injuries By Physical Agents	4 (.49%)
Ocular Neuromuscular	4 (.49%)
Oral Soft Tissue Conditions	4 (.49%)
Physical Examination Topics	4 (.49%)
Skin Appendage Conditions	4 (.49%)
Tongue Conditions	4 (.49%)
Hepatobiliary	3 (.37%)
Renal Disorders	3 (.37%)
Sleep Disturbances	3 (.37%)
Suicidal And Self-injurious Behavio...	3 (.37%)
Upper Respiratory Tract Disorders	3 (.37%)
Vascular	3 (.37%)
Water, Electrolyte And Mineral	3 (.37%)
Abortions And Stillbirth	2 (.24%)
Allergic Conditions	2 (.24%)
Aural	2 (.24%)
Electrolyte And Fluid Balance Condi...	2 (.24%)
Eye	2 (.24%)
Gastrointestinal Therapeutic Proced...	2 (.24%)
Glucose Metabolism Disorders	2 (.24%)
Hematology Investigations	2 (.24%)
Metabolic, Nutritional And Blood Ga...	2 (.24%)
Musculoskeletal And Connective Tiss...	2 (.24%)
Spleen, Lymphatic And Reticulendoth...	2 (.24%)
Structural Brain	2 (.24%)
White Blood Cell	2 (.24%)
Age Related Factors	1 (.12%)
Anemias Nonhemolytic And Marrow Dep...	1 (.12%)
Appetite And General Nutritional	1 (.12%)
Bone Disorders	1 (.12%)
Cardiac And Vascular Investigations	1 (.12%)
Eating Disorders	1 (.12%)
Endocrine Investigations	1 (.12%)
Gastrointestinal Tract Disorders Co...	1 (.12%)
Joint	1 (.12%)
Miscellaneous And Site Unspecified ...	1 (.12%)
Ocular Infections, Irritations And ...	1 (.12%)
Platelet	1 (.12%)
Pleural	1 (.12%)
Pregnancy, Labour, Delivery And Pos...	1 (.12%)
Skin And Subcutaneous Tissue	1 (.12%)
Vascular Hypertensive	1 (.12%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lamictal Xr, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lamictal Xr is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.